Antibody-induced secondary treatment failure in a patient treated with botulinum toxin type A for glabellar frown lines
Gabriele Stengel, Eva Kristina Bee Hautarztpraxis Stengel and Bee, Münster, Germany Abstract: Botulinum toxin type A (BTX-A) preparations are widely used nonsurgical treatments for facial wrinkles. Higher doses of BTX-A are also used for therapeutic purposes in the treatment of conditions...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2011-11-01
|
Series: | Clinical Interventions in Aging |
Online Access: | https://www.dovepress.com/antibody-induced-secondary-treatment-failure-in-a-patient-treated-with-peer-reviewed-article-CIA |